CSS
ALZN icon

Cubist Systematic Strategies’s Alzamend Neuro ALZN Stock Holding History

Cubist Systematic Strategies’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8
Closed -$5.36K – 3295
2023
Q2 		$5.36K Sell
8
-4
-33% -$3.13K ﹤0.01% 3303
2023
Q1 		$6.97K Hold
12
– – ﹤0.01% 3740
2022
Q4 		$9.26K Buy
+12
New +$17.4K ﹤0.01% 4050
2022
Q2 		– Sell
-28
Closed -$47K – 4343
2022
Q1 		$47K Buy
+28
New +$52.6K ﹤0.01% 3390
2021
Q4 		– Sell
-35
Closed -$144K – 3446
2021
Q3 		$144K Buy
35
+17
+94% +$93.4K ﹤0.01% 2665
2021
Q2 		$207K Buy
+18
New +$232K ﹤0.01% 2538

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IIC
Integrated Investment Consultants Bloomfield Hills, Michigan $471M AUM 20.31% 1-Year Est. Return

Cubist Systematic Strategies's ALZN Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Alzamend Neuro (ALZN) in Q3 2023, closing a stake of 8 shares — an estimated $5.36K sold.

Cubist Systematic Strategies first reported a position in ALZN in Q2 2021 and held it in 6 quarters. The position peaked at $207K in Q2 2021. 22 funds tracked by Wall St. Rank hold ALZN as of Q3 2023.

  • Cubist Systematic Strategies reported no remaining Alzamend Neuro position as of Q3 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 8 Alzamend Neuro shares in Q3 2023, an estimated $5.36K.
  • Cubist Systematic Strategies first reported a position in Alzamend Neuro in Q2 2021 and held it in 6 quarters.
  • Cubist Systematic Strategies's Alzamend Neuro position peaked at $207K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Alzamend Neuro as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.